Primary Invasive Breast Cancer
4 clinical trials · Condition
◉ Watch Primary Invasive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| EndoPredict® Extended Endocrine Trial (EXET) (NCT04016935) | Myriad Genetic Laboratories, Inc. | 2019-07-02 |
| Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer (NCT03503799) | North Eastern German Society of Gynaecological Oncology | 2018-07-17 |
| A Prototype Tri-modal Imaging Device for Breast Cancer (NCT02794064) | University Health Network, Toronto | 2016-05-01 |
| Capecitabine in Women With Operable Breast Cancer (NCT00148720) | Dana-Farber Cancer Institute | 2004-09-01 |
Track Primary Invasive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.